Pain measurement in rheumatic and musculoskeletal diseases: where to go from here? Report from a Special Interest Group at OMERACT 2018
- Chiarotto, A
- Kaiser, U
- Choy, E
- Christensen, R
- Conaghan, PG
- Cowern, M
- Gill, M
- de Wit, M
- Gargon, E
- Horgan, B
- Kirkham, JJ
- Simon, LS
- Singh, JA
- Tugwell, P
- Turk, DC
- Mease, PJ
Publication date
October 2019
DOI Publisher
The Journal of Rheumatology Language
EnglishAbstract
Objective: Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMDs). Methods: Discussion during a meeting at OMERACT 2018, prepared by a systematic review of existing core outcome sets and a patient online survey. Results: Several key questions were debated: is pain a symptom or a disease? are pain core (sub)domains consistent across RMDs? how to account for pain mechanistic descriptors (e.g. central sensitization) in pain measurement? Conclusion: Characterizing and assessing the spectrum of pain experience across RMDs in a standardized fashion is the future objective of the OMERACT pain working group
Add to ORKG